Atosiban

Therapeutic indications

Atosiban is indicated for:

Population group: women, only adults (18 - 65 years old)

Atosiban is indicated to delay imminent pre-term birth in pregnant women with:

regular uterine contractions of at least 30 seconds duration at a rate of ≥4 per 30 minutes
a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥50%
age ≥18 years
a gestational age from 24 until 33 completed weeks
a normal fetal heart rate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Atosiban is contraindicated in the following cases:

PPROM - Preterm premature rupture of membranes

Abnormal fetal heart rate

Antepartum hemorrhage

at least one of

Eclampsia

Severe pre-eclampsia

Fetal death

Infection of uterus

Placenta previa

Placental abruption